Morepen Laboratories Ltd. — Major Shareholding Notification 2021

Mar 26, 2021

Dated: March 26, 2021

To.

• 1. National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai- 400 051
• 1. Morepen Laboratories Limited Morepen Village, Nalagarh Road, Baddi, Distt. Solan, Himachal Pradesh - 173 205

• BSE Limited Floor 25, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

Subject: Disclosure required under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Dear Sir/Madam,

With reference to the above captioned subject, please note that, we, Brook Investments & Financial Services Private Limited, Concept Credits & Consultants Private Limited, Epitome Holdings Private Limited, Scope Credits & Financial Services Private Limited, Mid-Med Financial Services & Investments Private Limited, React Investments & Financial Services Private Limited, Solitary Investments & Financial Services Private Limited, Square Investments & Financial Services Private Limited, Solace Investments & Financial Services Private Limited and Seed Securities & Services Private Limited (hereinafter collectively referred as 'Acquirers') along with Liquid Holdings Private Limited, Arun Suri, Kanta Suri, Rajas Suri (KB Suri Sons HUF), Sanjay Suri (Sanjay Suri sons HUF), Praduman Lal Suri HUF, Sushil Suri (Sushil Suri Sons HUF), Anubhav Suri (Arun Suri Sons HUF), Mamta Suri, Sonia Suri, Sanjay Suri, P.L. Suri, Anju Suri, Sushil Suri, Sunita Suri, Shalu Suri, Varun Suri, Anubhav Suri, Sara Suri, Gulfy Suri, Aanchal Suri, Rajas Suri, Master Arjun Suri, Kanak Suri, Aanandi Suri and Baby Aakriti Suri (Hereinafter collectively referred to as 'PACs') was allotted 3,50,00,000 (Three Crores and Fifty Lakhs) Fully Convertible Warrants carrying a right to subscribe an equal number of Equity Shares of INR 2/- each on preferential basis by Morepen Laboratories Limited ('Target Company') in the meeting of its Board of Directors held on March 25, 2021.

Pursuant to the same, we are hereby submitting the disclosure required under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Kindly take the above information on your records.

For and/on behalf of Acquirers along with PACs

Sushil Suri

Authorised signatory

Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Name of the Target Company (TC)	Morepen Laboratories Limited
Names of the Acquirer and Persons Acting in	Brook Investments & Financial Services Private Limited
Concert (PAC) with the Acquirer	Concept Credits & Consultants Private Limited
	Epitome Holdings Private Limited
	Scope Credits & Financial Services Private Limited
	Mid-Med Financial Services & Investments Private Limited
	React Investments & Financial Services Private Limited
	Solitary Investments & Financial Services Private Limited
	Square Investments & Financial Services Private Limited
	Solace Investments & Financial Services Private Limited
	Seed Securities & Services Private Limited
	(Hereinafter collectively referred to as 'Acquirers')
	Liquid Holdings Private Limited
	Arun Suri
	Kanta Suri
	Rajas Suri (KB Suri Sons HUF)
	Sanjay Suri (Sanjay Suri sons HUF)
	Praduman Lal Suri HUF
	Sushil Suri (Sushil Suri Sons HUF)
	Anubhav Suri (Arun Suri Sons HUF)
	Mamta Suri
	Sonia Suri
	Sanjay Suri
	P.L. Suri
	Anju Suri Sushil Suri
	Sunita Suri
	Shalu Suri Varun Suri
	Anubhay Suri
	Sara Suri
	Gulfy Suri
	Aanchal Suri
	Rajas Suri
	Master Arjun Suri
	Kanak Suri
	Aanandi Suri
	Baby Aakriti Suri
	(Hereinafter collectively referred to as 'PACs')
Whether the Acquirer belongs to Promoter/	Yes

	Promoter group
Name(s) of the Stock Exchange(s) where the shares		National Stock Exchange of India Limited
	of TC are Listed	BSE Limited
Details of the acquisition as follows		Number	$\%$ w.r.t. total	$\%$ w.r.t.
			share/voting	total diluted
			capital	share/voting
			wherever	capital of
			applicable	the TC*
	Before the acquisition under consideration,
	holding of acquirer along with PAC of:
a)	Shares carrying voting rights
	Acquirers	11,41,26,838	25.37	25.37
	PACs	4, 12, 44, 750	9.17	9.17
b)	Shares in the nature of encumbrance (pledge/
	lien/ non-disposal undertaking/ others)
$\mathcal{C}$ )	Voting rights (VR) otherwise than by equity	Nil	NA	NA
	shares
$\mathrm{d}$ )	Warrants/convertible securities/any other	Nil	NA	NA
	instrument that entitles the acquirer to receive
	shares carrying voting rights in the TC
	(specify holding in each category)
		Nil	NA	NA
e)	Total $(a+b+c+d)$	15,53,71,588	34.54	$34.54*$
	Details of acquisition
a)	Shares carrying voting rights acquired	Nil	NA	NA
b)	VRs acquired otherwise than by equity shares
$\circ$ )	Warrants/convertible securities/any other	Nil	NA	NA
	instrument that entitles the acquirer to receive
	shares carrying voting rights in the TC
	(specify holding in each category) acquired.
	Acquirers
	Brook Investments & Financial Services
	Private Limited	35,00,000		0.72
	Concept Credits & Consultants Private
	Limited	35,00,000		0.72

$\bar{u}$

$\mathcal{H}$

	Epitome Holdings Private Limited	35,00,000		0.72
	- Scope Credits & Financial Services Private
	Limited	35,00,000		0.72
	- Mid-Med Financial Services & Investments
	Private Limited	35,00,000		0.72
	- React Investments & Financial Services
	Private Limited	35,00,000		0.72
	- Solitary Investments & Financial Services
	Private Limited	35,00,000		0.72
	- Square Investments & Financial Services
	Private Limited	35,00,000		0.72
	- Solace Investments & Financial Services
	Private Limited	35,00,000		0.72
	- Seed Securities & Services Private Limited
d)	Shares encumbered/invoked/released by the	35,00,000		0.72
	Acquirer
		Nil	NA	NA
e)	Total $(a+b+c+d)$	3,50,00,000		$7.22*$
After the acquisition, holding of acquirer along
with PACs of:
a)	Shares carrying voting rights
	Acquirers	11,41,26,838	25.37	23.54
	PACs	4, 12, 44, 750	9.17	8.51
	b) Shares encumbered with the Acquirer	Nil	NA	NA
$\mathcal{C}$ )	VRs otherwise than by equity shares	Nil	NA	NA
d)	Warrants/convertible securities/any other
	instrument that entitles the acquirer to receive
	shares carrying voting rights in the TC
	(specify holding in each category) after
	acquisition
	Acquirers	3,50,00,000		7.22
	PACs	Nil	NA	NA
e)	Total $(a+b+c+d)$	19,03,71,588	34.54	39.27*
	Mode of acquisition (e.g. open market / public		Preferential Allotment of Convertible Warrants
	issue / rights issue /preferential allotment / inter-se	through private placement

$\mathcal{S}^{\mathcal{A}}{\mathcal{A}}$ and $\mathcal{S}^{\mathcal{A}}{\mathcal{A}}$ and $\mathcal{S}^{\mathcal{A}}{\mathcal{A}}$ and $\mathcal{S}^{\mathcal{A}}{\mathcal{A}}$

transfer, etc.)
Date of acquisition of/ date of receipt of intimation	March 25, 2021
of allotment of shares/ VR/ warrants/convertible
securities/any other instrument that entitles the
acquirer to receive shares in the TC.
Equity share capital / total voting capital of the TC	INR 89,95,86,406 (Rupees Eighty Nine Crore
before the said acquisition	Ninety Five Lakh Eighty Six Thousand Four
	Hundred and Six Only) divided into 44,98,26,203
	(Forty Four Crore Ninety Eight Lakh Twenty Six
	Thousand Two Hundred and Three) Equity Shares
	of INR 2/- each.
Equity share capital/ total voting capital of the TC	INR 89,95,86,406 (Rupees Eighty Nine Crore
after the said acquisition	Ninety Five Lakh Eighty Six Thousand Four
	Hundred and Six Only) divided into 44,98,26,203
	(Forty Four Crore Ninety Eight Lakh Twenty Six
	Thousand Two Hundred and Three) Equity Shares
	of INR 2/- each.
Total diluted share/voting capital of the TC after	INR 96,95,86,406 (Rupees Ninety Six Crore
the said acquisition	Ninety Five Lakh Eighty Six Thousand Four
	Hundred and Six Only) divided into 48,48,26,203
	(Forty Eight Crore Forty Eight Lakh Twenty Six
	Thousand Two Hundred and Three) Equity Shares
	of INR 2/- each.

(*) percentages have been calculated after excluding the Optionally Convertible Preference Shares as conversion period has already been lapsed. However, the Optionally Convertible Preference Shares are entitled for voting rights equivalent to equity shareholders, therefore % of promoter in post issue diluted share capital company after considering the OCRPS is 35.68% (i.e., change of 4.51 %)

For and on behalf of Acquirers along with PACs

Sushil Suri (Authorised Signatory)

Place: New Delhi Date: March 26, 2021